全文获取类型
收费全文 | 9702篇 |
免费 | 574篇 |
国内免费 | 50篇 |
专业分类
耳鼻咽喉 | 81篇 |
儿科学 | 122篇 |
妇产科学 | 110篇 |
基础医学 | 1268篇 |
口腔科学 | 576篇 |
临床医学 | 892篇 |
内科学 | 2148篇 |
皮肤病学 | 103篇 |
神经病学 | 996篇 |
特种医学 | 269篇 |
外国民族医学 | 1篇 |
外科学 | 1837篇 |
综合类 | 29篇 |
一般理论 | 2篇 |
预防医学 | 533篇 |
眼科学 | 188篇 |
药学 | 635篇 |
中国医学 | 54篇 |
肿瘤学 | 482篇 |
出版年
2024年 | 12篇 |
2023年 | 116篇 |
2022年 | 232篇 |
2021年 | 409篇 |
2020年 | 225篇 |
2019年 | 343篇 |
2018年 | 425篇 |
2017年 | 277篇 |
2016年 | 289篇 |
2015年 | 356篇 |
2014年 | 487篇 |
2013年 | 577篇 |
2012年 | 876篇 |
2011年 | 872篇 |
2010年 | 474篇 |
2009年 | 434篇 |
2008年 | 627篇 |
2007年 | 636篇 |
2006年 | 559篇 |
2005年 | 517篇 |
2004年 | 401篇 |
2003年 | 334篇 |
2002年 | 275篇 |
2001年 | 56篇 |
2000年 | 33篇 |
1999年 | 43篇 |
1998年 | 39篇 |
1997年 | 32篇 |
1996年 | 25篇 |
1995年 | 13篇 |
1994年 | 13篇 |
1993年 | 10篇 |
1992年 | 20篇 |
1991年 | 23篇 |
1990年 | 14篇 |
1989年 | 10篇 |
1988年 | 32篇 |
1987年 | 20篇 |
1986年 | 24篇 |
1985年 | 10篇 |
1984年 | 11篇 |
1983年 | 12篇 |
1982年 | 9篇 |
1980年 | 6篇 |
1979年 | 16篇 |
1978年 | 7篇 |
1975年 | 9篇 |
1974年 | 13篇 |
1973年 | 11篇 |
1972年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
11.
Dany Anglicheau Alexandre Lautrette Catherine Scieux Martin Flamant Frédéric Morinet Christophe Legendre 《Nephrology, dialysis, transplantation》2003,18(8):1654-1656
BACKGROUND: Routine cytomegalovirus (CMV)-pp65 antigenaemia monitoring shows that some patients will develop pp65 antigenaemia during valaciclovir prophylaxis or after cessation of treatment. The aim of this pilot study was to evaluate the safety and efficacy of lowering immunosuppression in kidney transplant recipients who exhibit mildly symptomatic CMV infections while on valaciclovir prophylaxis. METHODS: We selected 12 patients who experienced mildly symptomatic CMV infections defined as a positive CMV-pp65 antigenaemia test associated with either neutropenia, asthenia or arthralgia, but no fever. All of them received prophylaxis with valaciclovir for at least 3 months. Testing for CMV-pp65 antigenaemia was performed weekly for 6 months. RESULTS: The mildly symptomatic infections occurred at a median interval of 69 days after transplantation-during prophylaxis in eight cases and after valaciclovir discontinuation in the other four cases. All of them were effectively managed by lowering immunosuppressive therapy, leading to the disappearance of symptoms and CMV antigenaemia reduction. No immunological complication or recurrence of CMV infection or disease was noted. I.v. ganciclovir never became necessary. CONCLUSION: The mildly symptomatic CMV infections occurring in valaciclovir-treated patients may be managed efficiently and without immunologic complication by lowering immunosuppressive therapy. 相似文献
12.
Thomas Rimmelé Sophie Malhière Alexandre Ben Cheikh Emmanuel Boselli Monique Bret Charles-Eric Ber Paul Petit Bernard Allaouchiche 《Journal canadien d'anesthésie》2007,54(8):652-656
PURPOSE: In France, legislation mandates that the clinical diagnosis of brain death be confirmed by one paraclinical test before organ donation is allowed. That test may be either the electroencephalogram (EEG) or cerebral angiography. We report a case in which the clinical diagnosis of brain death was first confirmed by two EEGs performed according to the French guidelines, but ruled out by cerebral angiography. Considering that the EEG is no longer recommended to establish the diagnosis of brain death, we discuss the relevance of maintaining the EEG for brain death diagnosis in France. CLINICAL FINDINGS: A 58 yr-old man was admitted to the intensive care unit because of coma secondary to a massive subarachnoid hemorrhage with herniation below the falx shown by computed tomography. Clinical criteria of brain death were rapidly present. Two EEGs first confirmed the diagnosis but a four-vessel cerebral angiography was finally performed because the patient moved spontaneously. This cerebral angiography showed flow in the right internal carotid artery. A computed tomography performed the next day definitely confirmed the absence of brain death and organ donation did not occur. CONCLUSIONS: This case demonstrates the limitations of the EEG for this indication and suggests that angiography should be preferred. French legislation is probably maladjusted and would benefit by incorporating guidelines of other countries like Canada. International harmonization of criteria for brain death diagnosis would also be welcome. 相似文献
13.
14.
15.
Antoine Feydy MD PhD Alexandre Krainik MD Bernard Bussel MD Marc A. Maier PhD 《Journal of neuroimaging》2004,14(1):49-53
The authors report the case of a 33-year-old woman who exhibited, at the age of 17, a left-sided hemiplegia, which was followed by good motor recovery, though with a permanent deficit in fine finger movements. She had a widespread loss of neural tissue in the right hemisphere (crossed cerebrocerebellar atrophy), including (1) marked atrophy and thinning of the precentral and postcentral gyri; (2) widespread deep white matter destruction, including the corticospinal tract; and (3) crossed cerebellar atrophy. Except over the supplementary motor area (SMA), transcranial magnetic stimulation did not elicit motor evoked potentials in the affected hand. Nevertheless, during opening and closing of the affected hand, functional magnetic resonance imaging showed an activation of the lesioned primary sensorimotor cortex (SMC), as well as of the intact SMA and the parietal areas, but not of the ipsilateral motor areas. The authors speculate that recovery was achieved by a motor command generated in the SMC and the parietal cortex, passing through corticospinal axons originating in the SMA. 相似文献
16.
17.
Louis Boyer Jean M. Delorme Marc Alexandre Annie Boissier Pierre Gimbergues Gérard Glanddier J. Francois Viallet 《Cardiovascular and interventional radiology》1994,17(4):214-216
A 66-year-old man with atrial fibrillation was referred soon after developing left lower limb and abdominal pain with rectal bleeding. An immediate flush aortogram showed embolic occlusion of the left distal superficial femoral artery and superior mesenteric artery (SMA), 3 cm from its ostium. Recombinant tissue plasminogen activitor (rtPA) 40 mg was selectively in stilled in the SMA in two boluses. Abdominal symptoms resolved within 48 h, and complete recanalization of the SMA was shown on angiography. Exploratory laparotomy after 72 h showed a normal small bowel and right colon, and was completed by femoropopliteal embolectomy. Six months later, the patient remained asymptomatic. 相似文献
18.
19.
Functional signatures of protective antiviral T-cell immunity in human virus infections 总被引:9,自引:0,他引:9
Alexandre Harari Valérie Dutoit Cristina Cellerai Pierre-Alexandre Bart Renaud A. Du Pasquier & Giuseppe Pantaleo 《Immunological reviews》2006,211(1):236-254
Summary: The most common human viruses have different abilities to establish persistent chronic infection. Virus‐specific T‐cell responses are critical in the control of virus replication and in the prevention of disease in chronic infection. A large number of phenotypic markers and a series of functions have been used to characterize virus‐specific CD4+ and CD8+ T‐cell responses, and these studies have shown great phenotypic and functional heterogeneity of the T‐cell responses against different viruses. The heterogeneity of the T‐cell response has been proposed to be specific to each virus. However, over the past 2 years, several studies have provided evidence that the phenotypic and functional heterogeneity of CD4+ and CD8+ T‐cell responses is predominantly regulated by the levels of antigen load. The levels of antigen load modulate the phenotypic and functional patterns of the T‐cell response within the same virus infection. Furthermore, the functional characterization of virus‐specific CD4+ and CD8+ T‐cell responses has identified signatures of protective antiviral immunity. Polyfunctional, i.e. interleukin‐2 and interferon‐γ (IFN‐γ) secretion and proliferation, and not monofunctional, i.e. IFN‐γ secretion, CD4+ and CD8+ T‐cell responses represent correlates of protective antiviral immunity in chronic virus infections. 相似文献
20.
Alexandre Castro-Caldas Paul Delwaide Wolfgang Jost Marcelo Merello Adrian Williams Paolo Lamberti Miguel Aguilar Susanna Del Signore Pierre Cesaro 《Movement disorders》2006,21(4):500-509
Dopamine agonists have been recommended as early treatment for Parkinson's disease (PD), alone or combined with levodopa. Piribedil is a non-ergot selective D(2)/D(3) agonist with alpha(2) antagonist properties shown to be effective in the treatment of PD. This 12-month international, randomized, double-blind trial aimed to assess the efficacy of piribedil 150 mg versus bromocriptine 25 mg, in early combination with levodopa in Stage I to III PD patients. Motor efficacy was assessed using the Unified Parkinson's Disease Rating Scale (UPDRS III, Items 18-31) as improvement from baseline. Response rate was defined as a 30% improvement. Among the 425 randomly assigned patients, 178 were also included in a substudy on cognitive follow-up evaluated by a dysexecutive syndrome oriented battery. A relevant improvement in UPDRS III over the 12-month study duration was observed both in the piribedil and bromocriptine groups (-7.9 +/- 9.7 points from baseline versus -8.0 +/- 9.5; not significant [n.s.]) with a response rate of 58.4% and 55.3% (n.s.), respectively. Piribedil and bromocriptine resulted in similar improvement on all UPDRS III subscores. Piribedil patients required less levodopa dose increase than those on bromocriptine. Cognitive performance remained generally unchanged in both groups, with a significant effect of piribedil limited to the Wisconsin Card Sorting Test. An overall good tolerability of piribedil was observed. Early combination of piribedil 150 mg with levodopa resulted in significant long-term improvement of all motor symptoms in PD patients insufficiently controlled by levodopa alone. Taking into account both efficacy and acceptability in the long-term, piribedil proved in this bromocriptine controlled study to be an effective and safe treatment for PD. 相似文献